These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26374482)

  • 1. Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial.
    Matz K; Teuschl Y; Firlinger B; Dachenhausen A; Keindl M; Seyfang L; Tuomilehto J; Brainin M;
    Stroke; 2015 Oct; 46(10):2874-80. PubMed ID: 26374482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics.
    Brainin M; Matz K; Nemec M; Teuschl Y; Dachenhausen A; Asenbaum-Nan S; Bancher C; Kepplinger B; Oberndorfer S; Pinter M; Schnider P; Tuomilehto J;
    Int J Stroke; 2015 Jun; 10(4):627-35. PubMed ID: 24206541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of multiple domain interventions on lifestyle and risk factor changes in stroke survivors: Evidence from a two-year randomized trial.
    Teuschl Y; Matz K; Firlinger B; Dachenhausen A; Tuomilehto J; Brainin M;
    Int J Stroke; 2017 Dec; 12(9):976-984. PubMed ID: 28355960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.
    Ngandu T; Lehtisalo J; Solomon A; Levälahti E; Ahtiluoto S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lindström J; Mangialasche F; Paajanen T; Pajala S; Peltonen M; Rauramaa R; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    Lancet; 2015 Jun; 385(9984):2255-63. PubMed ID: 25771249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial.
    Lam LC; Chan WC; Leung T; Fung AW; Leung EM
    PLoS One; 2015; 10(3):e0118173. PubMed ID: 25826620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifactorial vascular risk factor intervention to prevent cognitive impairment after stroke and TIA: a 12-month randomized controlled trial.
    Ihle-Hansen H; Thommessen B; Fagerland MW; Øksengård AR; Wyller TB; Engedal K; Fure B
    Int J Stroke; 2014 Oct; 9(7):932-8. PubMed ID: 23205666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial.
    Lautenschlager NT; Cox KL; Flicker L; Foster JK; van Bockxmeer FM; Xiao J; Greenop KR; Almeida OP
    JAMA; 2008 Sep; 300(9):1027-37. PubMed ID: 18768414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
    Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
    Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait measures as predictors of poststroke cognitive function: evidence from the TABASCO study.
    Ben Assayag E; Shenhar-Tsarfaty S; Korczyn AD; Kliper E; Hallevi H; Shopin L; Auriel E; Giladi N; Mike A; Halevy A; Weiss A; Mirelman A; Bornstein NM; Hausdorff JM
    Stroke; 2015 Apr; 46(4):1077-83. PubMed ID: 25677599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of post-stroke cognitive decline: a review focusing on lifestyle interventions.
    Teuschl Y; Matz K; Brainin M
    Eur J Neurol; 2013 Jan; 20(1):35-49. PubMed ID: 22672523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a multidomain lifestyle modification on cognitive function in older adults: an eighteen-month community-based cluster randomized controlled trial.
    Lee KS; Lee Y; Back JH; Son SJ; Choi SH; Chung YK; Lim KY; Noh JS; Koh SH; Oh BH; Hong CH
    Psychother Psychosom; 2014; 83(5):270-8. PubMed ID: 25116574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis.
    Teuschl Y; Ihle-Hansen H; Matz K; Dachenhausen A; Ratajczak P; Tuomilehto J; Ursin MH; Hagberg G; Thommessen B; Øksengård AR; Brainin M;
    Eur J Neurol; 2018 Sep; 25(9):1182-1188. PubMed ID: 29782693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-Based Intervention to Improve Cardiometabolic Targets in Patients With Stroke: A Randomized Controlled Trial.
    Olaiya MT; Cadilhac DA; Kim J; Nelson MR; Srikanth VK; Gerraty RP; Bladin CF; Fitzgerald SM; Phan T; Frayne J; Thrift AG
    Stroke; 2017 Sep; 48(9):2504-2510. PubMed ID: 28754834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.
    Sindi S; Ngandu T; Hovatta I; Kåreholt I; Antikainen R; Hänninen T; Levälahti E; Laatikainen T; Lindström J; Paajanen T; Peltonen M; Khalsa DS; Wolozin B; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M; Solomon A;
    J Alzheimers Dis; 2017; 59(4):1459-1470. PubMed ID: 28777749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST).
    Scutt P; Blackburn D; Krishnan K; Ballard C; Burns A; Ford GA; Mant J; Passmore P; Pocock S; Reckless J; Sprigg N; Stewart R; Wardlaw JM; Bath PM
    Trials; 2015 Nov; 16():509. PubMed ID: 26545986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
    Snitz BE; O'Meara ES; Carlson MC; Arnold AM; Ives DG; Rapp SR; Saxton J; Lopez OL; Dunn LO; Sink KM; DeKosky ST;
    JAMA; 2009 Dec; 302(24):2663-70. PubMed ID: 20040554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Rationale for a Cognitive Outcome Substudy in Ischemic Stroke Patients with High Risk of Cerebral Hemorrhage.
    Yu KH; Hong KS; Oh MS; Lee J; Lee JS; Kwon SU;
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2061-6. PubMed ID: 27263034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD).
    McMaster M; Kim S; Clare L; Torres SJ; Cherbuin N; DʼEste C; Anstey KJ
    J Am Geriatr Soc; 2020 Nov; 68(11):2629-2637. PubMed ID: 32909259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.